Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.99
-0.0400-1.32%
Post-market: 2.990.00000.00%19:08 EDT
Volume:106.72K
Turnover:326.16K
Market Cap:58.32M
PE:-1.55
High:3.15
Open:3.02
Low:2.99
Close:3.03
Loading ...

NRx Pharmaceuticals initiated with a Buy at BTIG

TIPRANKS
·
02 Apr

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Mar

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Definitive Purchase Agreement With Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

THOMSON REUTERS
·
31 Mar

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

Dow Jones
·
31 Mar

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
24 Mar

NRx Pharmaceuticals Unit Signs Letter of Intent to Acquire Neurospa TMS

MT Newswires Live
·
24 Mar

BRIEF-HOPE Therapeutics and NRx Pharmaceuticals Sign Binding Letter of Intent with Neurospa TMS Holdings

Reuters
·
24 Mar

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Signing of Binding Letter of Intent With Neurospa Tms Holdings, Llc for Expansion of Its Planned International Network of Interventional Psychiatry Clinics

THOMSON REUTERS
·
24 Mar

Hope Therapeutics : Acquisition to Be Accretive to Hope Revenue Projections for 2025

THOMSON REUTERS
·
24 Mar

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics

Dow Jones
·
24 Mar

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Mar

NRX Pharmaceuticals Inc (NRXP) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial ...

GuruFocus.com
·
18 Mar

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
17 Mar

NRX Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
17 Mar

NRX Pharmaceuticals Inc - Forecasts Profitability by Year End 2025

THOMSON REUTERS
·
17 Mar

Press Release: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
17 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar